South Korea-based Hanmi Pharmaceutical has reported positive outcomes from a Phase I/II clinical trial of Tivumecirnon ...

Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...

Most companies don't survive for decades, much less pay regular dividends for that long. Healthcare leaders Merck (NYSE: MRK) ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...

The entertainment company plans to add more live ESPN shows to its main streaming service, saying customers want simplicity. The company's shares rose as investors breathed a sigh of relief on strong ...

The app, which pioneered commission-free trading, amassed 13 million user accounts and gained significant brand recognition ... with its leading cancer medication, Keytruda, revolutionizing treatment ...

Still, it remains an iconic brand with some of the most cutting edge TVs out there. It pushes the envelope with its QD-OLED technology, whilst offering some of the brightest and boldest QLED TVs.

Cigna recorded more high-cost claims due to increased usage of specialty medications such Merck's (MRK.N), opens new tab blockbuster cancer therapy Keytruda and other inpatient surgeries like ...

These vary with the plan, the medications, and whether a person uses generic or brand-name drugs. To provide an idea of immunotherapy expenses, the sections below show the costs for two ...

What's in a name? A lot, actually. The right brand name can make your business stand out, connect with customers emotionally, and convey what you're all about. But choosing that perfect moniker is ...